GlassScriptPhysician profile
Marlen S Strefling
NPI 1316981020
$2,169.01
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $300 · 2021: $241 · 2022: $306 · 2023: $482 · 2024: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $427.64 | 2022-2024 | Saphnelo, Tezspire |
| Horizon Therapeutics Plc | $284.74 | 2019-2023 | Krystexxa |
| Allergan, INC. | $205.03 | 2019-2020 | |
| Novo Nordisk INC | $204.43 | 2021-2022 | |
| Amgen INC. | $191.74 | 2019-2020 | |
| Abbvie INC. | $184.33 | 2020-2022 | |
| Gilead Sciences, INC. | $179.55 | 2021-2024 | Epclusa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.23 | 2024 | Xifaxan |
| Janssen Pharmaceuticals, INC | $101.08 | 2019 | |
| Amarin Pharma, INC. | $86.30 | 2019 | |
| Globus Medical, INC. | $82.72 | 2023-2024 | External Fixation, Distal Fibula Plate, Distal Radius Plate |
| Antares Pharma, INC. | $76.95 | 2023 | Tlando, Nocdurna, Xyosted |
| Abbott Laboratories | $30.27 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlen Strefling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.